Characteristics and Outcomes of Mycoplasma Pneumoniae Pneumonia Associated with Pulmonary Embolism and Necrotizing Pneumonia in Children
DOI: https://doi.org/10.2147/idr.s459626
2024-05-18
Infection and Drug Resistance
Abstract:Chenlu Wang, 1, 2 Lanxin Li, 1, 2 Gang Xiao, 1– 3 Yuanyuan Chen, 1, 2 Yingshuo Wang, 1, 2 Zhimin Chen, 1, 2 Yunlian Zhou 1, 2 1 Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; 2 National Clinical Research Center for Child Health, Hangzhou, Zhejiang, People's Republic of China; 3 Department of Pediatrics, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China Correspondence: Yunlian Zhou; Zhimin Chen, Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, No. 3333. Binsheng Road, Hangzhou, Zhejiang, People's Republic of China, Email ; Purpose: To explore the clinical characteristics, treatment, and long-term prognosis of mycoplasma pneumoniae pneumonia (MPP) combined with pulmonary embolism (PE) in children. Patients and Methods: The medical records of 16 children who were diagnosed with MPP associated with PE between January 2016 and January 2023 at Children's Hospital, Zhejiang University School of Medicine were retrospectively reviewed. Results: The average age patients were 8.24 ± 1.99 years. All cases were diagnosed with refractory mycoplasma pneumoniae pneumonia (RMPP) and presented complications in the form of necrotizing pneumonia (NP). The main symptoms observed were cough and fever (n = 16, 100%), chest pain (n = 8, 50%), dyspnea (n = 8, 50%), and hemoptysis (n = 4, 25%). In these cases, 12 patients had involvement of the pulmonary artery, 3 patients experienced issues with the pulmonary vein, and 1 patient had simultaneous involvement of both the pulmonary artery and pulmonary vein. Among the 12 pulmonary artery embolism cases, 6 involved the right pulmonary artery, 4 involved the left pulmonary artery, and 2 involved both the right and left pulmonary arteries. The mean D-dimer level was 8.50 ± 4.76 mg/L. All patients received anticoagulant therapy, and after treatment, there was a significant improvement in their symptoms and lung lesions. Conclusion: Children with RMPP, chest pain, hemoptysis, and elevated D-dimer levels should be closely monitored for the potential development of PE. The co-occurrence of MPP and PE often involves the presence of NP. In cases of confirmed PE, anticoagulation therapy may be a suitable consideration. PE and NP resulting from MPP generally had a favorable overall prognosis. Keywords: mycoplasma pneumoniae, pulmonary embolism, necrotizing pneumonia, children Mycoplasma pneumoniae (MP) is an important pathogen of respiratory tract infections that can cause up community-acquired pneumonia (CAP) in children. 1,2 Typically, mycoplasma pneumoniae pneumonia (MPP) is characterized by mild, self-limiting symptoms. However, there have been recent cases where MPP has led to both pulmonary and extrapulmonary complications, such as necrotizing pneumonia (NP), pulmonary embolism (PE), cerebral infarction, myocarditis, hemolytic anemia, Stevens–Johnson syndrome, and erythema multiforme. 3–5 PE is one of the rarest extrapulmonary complications that has been reported in previous studies. However, few literature had concentrated on MPP associated with PE. Here, we describe 16 pediatric MPP associated with PE cases with diverse clinical manifestations. The aim of this study is to advance clinical experience for the diagnosis and treatment of such diseases. In this study, we retrospectively collected the clinical data of 16 MPP patients with PE who were admitted to Children's hospital, Zhejiang University School of Medicine between January 1, 2016, and January 31, 2023. We collected relevant information including medical manifestations, inflammatory indicators such as C-reactive protein (CRP) and lactate dehydrogenase (LDH), and the results of blood coagulation studies such as D-dimer levels, Protein C activity, Protein S activity and Antithrombin-III. Besides, the results of contrast-enhanced lung CT, blood vessel ultrasonography, treatments and outcomes were all recorded. CT was performed using 64-MDCT scanners (GE, America) for all patients, and the standard scanning parameters were as following: slice thickness of 0.625 mm, 1.375 pitch120 kV, and automated mA. Philips iE33 type (probe frequency 1 ~ 5 MHz, load Blue Royal Philips), Vivid E9 (probe frequency 3 ~8 MHz, US GE) Doppler ultrasonic diagnostic instrument for detection survey. The diagnostic standard for MPP was defined as follows: 6,7 (1) signs and symptoms indicative of CAP, including fever, cough, abnormal lung auscultation and new infiltrate(s) on chest radiograph; (2) had both positive -Abstract Truncated-
pharmacology & pharmacy,infectious diseases